PEG4-aminooxy-MMAF

PEG4-aminooxy-MMAF

• Product Name Alternative: Amberstatin; AS269
• CAS Number: 1415246-35-3
• UNSPSC Description: PEG4-aminooxy-MMAF is a agent-linker conjugate for ADC with potent antitumor activity by using the potent antitubulin agent MMAF, linked via the noncleavable PEG4[1].
• Target Antigen: Drug-Linker Conjugates for ADC; Microtubule/Tubulin
• Type: ADC Related
• Related Pathways: Antibody-drug Conjugate/ADC Related;Cell Cycle/DNA Damage;Cytoskeleton
• Field of Research: Cancer; Inflammation/Immunology
• Assay Protocol: https://www.medchemexpress.com/peg4-linker.html
• Purity: 99.83
• Solubility: DMSO : 100 mg/mL (ultrasonic)|H2O : ≥ 100 mg/mL
• Smiles: OC([C@H](CC1=CC=CC=C1)NC([C@H](C)[C@H]([C@@]2([H])N(CCC2)C(C[C@@H](OC)[C@H]([C@@H](C)CC)N(C)C([C@H](C(C)C)NC([C@H](C(C)C)N(C)CCOCCOCCOCCON)=O)=O)=O)OC)=O)=O
• Molecular Weight: 923.19
• References & Citations: [1]Samantha Congreve, et al. Antibody drug conjugates (ADC). Teknisk- naturvetenskaplig fakultet
• Shipping Conditions: Blue Ice
• Storage Conditions: -20°C (Powder, protect from light)
• Clinical Information: No Development Reported